These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 24438721

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: results from the EUROASPIRE III survey.
    De Smedt D, Clays E, Annemans L, Doyle F, Kotseva K, Pająk A, Prugger C, Jennings C, Wood D, De Bacquer D.
    Int J Cardiol; 2013 Sep 30; 168(2):898-903. PubMed ID: 23201081
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort.
    Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B.
    J Rheumatol; 2011 Aug 30; 38(8):1576-84. PubMed ID: 21532054
    [Abstract] [Full Text] [Related]

  • 5. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S, Hockley C.
    Health Econ; 2005 Nov 30; 14(11):1169-89. PubMed ID: 15942981
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the EuroQol and short form 6D in Singapore multiethnic Asian knee osteoarthritis patients scheduled for total knee replacement.
    Xie F, Li SC, Luo N, Lo NN, Yeo SJ, Yang KY, Fong KY, Thumboo J.
    Arthritis Rheum; 2007 Aug 15; 57(6):1043-9. PubMed ID: 17665466
    [Abstract] [Full Text] [Related]

  • 7. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.
    Bharmal M, Thomas J.
    Value Health; 2006 Aug 15; 9(4):262-71. PubMed ID: 16903996
    [Abstract] [Full Text] [Related]

  • 8. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
    Zhao FL, Yue M, Yang H, Wang T, Wu JH, Li SC.
    Value Health; 2010 Aug 15; 13(5):649-56. PubMed ID: 20412540
    [Abstract] [Full Text] [Related]

  • 9. Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients.
    De Smedt D, Clays E, Doyle F, Kotseva K, Prugger C, Pająk A, Jennings C, Wood D, De Bacquer D, EUROASPIRE Study Group.
    Int J Cardiol; 2013 Sep 01; 167(5):2294-9. PubMed ID: 22748284
    [Abstract] [Full Text] [Related]

  • 10. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.
    Hawton A, Green C, Telford C, Zajicek J, Wright D.
    Value Health; 2012 Dec 01; 15(8):1084-91. PubMed ID: 23244811
    [Abstract] [Full Text] [Related]

  • 11. How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
    Boonen A, van der Heijde D, Landewé R, van Tubergen A, Mielants H, Dougados M, van der Linden S.
    Ann Rheum Dis; 2007 Jun 01; 66(6):771-7. PubMed ID: 17213254
    [Abstract] [Full Text] [Related]

  • 12. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F, Carotti M, Ciapetti A, Gasparini S, Grassi W.
    Clin Exp Rheumatol; 2011 Jun 01; 29(4):661-71. PubMed ID: 21813061
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD).
    Yang F, Lau T, Lee E, Vathsala A, Chia KS, Luo N.
    Eur J Health Econ; 2015 Dec 01; 16(9):1019-26. PubMed ID: 25519850
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease.
    van Stel HF, Buskens E.
    Health Qual Life Outcomes; 2006 Mar 25; 4():20. PubMed ID: 16563170
    [Abstract] [Full Text] [Related]

  • 15. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
    Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, Block JA, Jolly M.
    J Rheumatol; 2009 Jun 25; 36(6):1209-16. PubMed ID: 19369452
    [Abstract] [Full Text] [Related]

  • 16. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG, Norman R, Brazier JE, Viney R.
    Value Health; 2014 Jul 25; 17(5):570-7. PubMed ID: 25128050
    [Abstract] [Full Text] [Related]

  • 17. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH, Lang BHH, Yu HMS, Lam CLK.
    Patient; 2017 Aug 25; 10(4):447-454. PubMed ID: 28224296
    [Abstract] [Full Text] [Related]

  • 18. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD).
    Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM.
    Value Health; 2011 Aug 25; 14(5):732-9. PubMed ID: 21839412
    [Abstract] [Full Text] [Related]

  • 19. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T, Noparatayaporn P, Sritippayawan S, Aiyasanon N.
    Value Health Reg Issues; 2019 May 25; 18():59-64. PubMed ID: 30502661
    [Abstract] [Full Text] [Related]

  • 20. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry.
    Buitinga L, Braakman-Jansen LM, Taal E, Kievit W, Visser H, van Riel PL, van de Laar MA.
    Arthritis Care Res (Hoboken); 2012 Jun 25; 64(6):826-32. PubMed ID: 22262513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.